Overview

Regulatory Post Marketing Surveillance Study in Korea

Status:
Completed
Trial end date:
2017-08-11
Target enrollment:
Participant gender:
Summary
The objective of the study is to investigate and collect post marketing data on the safety and efficacy of Visanne at follow-up visit after about 6 months of treatment and - for a subset of patients - at optional long-term follow-up visit after about 1 year of treatment under daily practice treatment conditions in Korean women and to obtain data on drug utilization on treatment for endometriosis.
Details
Lead Sponsor:
Bayer
Treatments:
Dienogest